We all play a role in the health of our local and global communities

To improve health outcomes worldwide, we are working to help build thriving health ecosystems and remove barriers to accessibility. Our Healthier Communities campaign highlights the ways we work toward this goal with our customers, for the patients, and in the communities where our colleagues live and work.

We advance health equity through efforts like making diagnostic tests more accessible, enabling diversity in clinical trials, and helping communities build their capacity to address disease. We also partner with customers who share our vision of a world where everyone has a fair and just opportunity to attain their highest level of health. Our colleagues extend this passion by volunteering with or supporting local charitable organizations.

We all play a role in the health of our local and global communities. Together, we can build a brighter future for our customers and all of society. We invite you to explore the content on this page to learn more about specific Thermo Fisher programs designed to enable healthier communities.

Thermo Fisher is continually working to improve health equity through its Healthier Communities Initiative. Joining Terri to share the details of the global program on this episode are guests Fred Lowery, executive vice president and president, Laboratory Products and BioProduction, and Meron H. Mathias, vice president of Corporate Social Responsibility and Sustainability.

Listen to the conversation as they discuss:

• How health equity is a key component of Thermo Fisher’s core business.
• How Thermo Fisher leverages its capabilities and customer relationships to further its impact.
• Initiatives that improve health equity through accessibility to drug-resistant HIV testing, next-generation sequencing to diagnose lung and breast cancer in 30 underserved countries, increasing the accessibility to and diversity in clinical trials, and more.
• New programs in 2024.

Dr. Blackburne, a thought leader in women’s health and clinical trials, emphasizes the critical need for diversity in clinical trials to achieve health equity, highlighting how different populations experience varying symptoms and responses to treatments. She also explains why, historically, women were excluded from clinical trials and recent measures that are helping to ensure equitable representation.

Listen to the conversation as they discuss:

• The challenges of recruiting women and minority groups for clinical trials, noting the logistical and societal barriers they face.
• Innovative solutions, such as telemedicine and flexible scheduling, to make trial participation more accessible.
• Recent advances in clinical research, including a groundbreaking preeclampsia test and contributions to COVID-19 vaccine trials, highlighting Thermo Fisher's pivotal role in these developments.